News Releases Year All Years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard January 2025 Sun Mon Tue Wed Thu Fri Sat 2930311234567891011121314151617181920212223242526272829303112345678 Cancel Go January 2025 Sun Mon Tue Wed Thu Fri Sat 2930311234567891011121314151617181920212223242526272829303112345678 Cancel Go Email Alerts Jul 15, 2013 Insmed Announces Proposed Public Offering of Common Stock Jul 8, 2013 Insmed to Present at the 8th Annual JMP Securities Healthcare Conference Jul 1, 2013 ARIKACE Meets Primary Endpoint of Non-Inferiority to TOBI in Phase 3 Clinical Trial in Europe and Canada to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients ARIKACE Receives Qualified Infectious Disease Product and Fast Track Designations from the U.S. FDA for the Treatment of Non-Tuberculous Mycobacteria Lung Infections Jun 28, 2013 Insmed to Join the Russell Global(R) and Russell 3000(R) Indexes Jun 28, 2013 Insmed to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis May 14, 2013 Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe May 13, 2013 Insmed to Present at the UBS Global Healthcare Conference May 10, 2013 Insmed to Present at the Bank of America Merrill Lynch 2013 Health Care Conference May 7, 2013 Insmed Reports First Quarter Financial Results May 1, 2013 Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013 Show 10Open per page«1…35363738394041…73» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up Stay In The Loop View the latest Insmed Investor Presentation Download